Prescriber Profiling

  1. Stephen E. Pratt, MD
  1. From Oak Tree Internal Medicine, San Ramon, CA 94583.

    TO THE EDITOR:

    I agree with Grande's sentiment (1), but I find the line of reasoning to be something of a non sequitur.

    Grande is advocating that physicians discontinue participation in pharmaceutical market research and that the sale of physician prescribing data should end. This would be in order to “roll back the influences of commercial marketing practices on clinical decisions.”

    Whereas these actions may be desirable for other reasons, neither would address the primary …

    [Full Text of this Article]
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med January 1, 2008 vol. 148 no. 1 81-82
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues